GCM
AMGN icon

Grisanti Capital Management’s Amgen AMGN Stock Holding History

Grisanti Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,582
Closed -$7.06M – 66
2017
Q4 		$7.06M Sell
40,582
-3,417
-8% -$605K 2.9% 15
2017
Q3 		$8.2M Buy
43,999
+129
+0.3% +$22.9K 3.37% 13
2017
Q2 		$7.55M Buy
+43,870
New +$7.14M 3.25% 14

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Grisanti Capital Management's AMGN Position: Q1 2018 in Review

Grisanti Capital Management sold out of Amgen (AMGN) in Q1 2018, closing a stake of 40,582 shares — an estimated $7.06M sold.

Grisanti Capital Management first reported a position in AMGN in Q2 2017 and held it in 3 quarters. The position peaked at $8.2M in Q3 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • Grisanti Capital Management reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • Grisanti Capital Management sold 40,582 Amgen shares in Q1 2018, an estimated $7.06M.
  • Grisanti Capital Management first reported a position in Amgen in Q2 2017 and held it in 3 quarters.
  • Grisanti Capital Management's Amgen position peaked at $8.2M in Q3 2017.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on Grisanti Capital Management's 13F filing for Q1 2018, filed 2 May 2018.